Sosei Heptares

Female doctor in protective workwear taking nose swab test from middle aged man wearing protective face mask
Cue Health to develop Omicron genotyping COVID-19 test and other digital health briefs
By Emily Olsen | 03:24 pm | January 06, 2022
Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.